Six game-changing technologies targeted at disease areas ranging from treatment of autoimmunity, to cancer, glaucoma to receive funding and Bayer mentoring.
Generating Superior ‘Killers’ for Adoptive Cell Therapy in Cancer, Lydia Lynch, PhD, Brigham and Women’s Hospital
Novel Strategies to Enhance Tfr Treatment of Autoimmunity, Peter Sage, PhD, Brigham and Women’s Hospital
Long-Lasting mRNA Therapy for Genetic Disorders, Jinjun Shi, PhD, Brigham and Women’s Hospital
AAV-Based Gene Replacement Therapy Improves Targeting and Clinical Outcomes in a Childhood CNS Disorder, Yulia Grishchuk, PhD, Massachusetts General Hospital
Towards a Permanent Genetic Cure for Spinal Muscular Atrophy, Benjamin Kleinstiver, PhD, Massachusetts General Hospital
Differentiation of Retinal Neurons for Cell Replacement in Glaucoma, Petr Baranov, MD, PhD, Massachusetts Eye and Ear
Most Recent Posts:
Innovation Grand Rounds: Investing in your Home-Grown Innovations
Innovation Grand Rounds is a monthly live series with talks by innovators and executives from across the…
Four Brigham Ignite Awards Announced
Innovations focus on CT-guided neurosurgery, knee osteoarthritis, brain tumors, and C-sections BOSTON, MA – September 7,…
Artificial Intelligence Model Outperforms Clinicians in Diagnosing Pediatric Ear Infections
In collaboration with Mass General Brigham Innovation, OtoDx is currently being employed in a prototype device paired…
